|
1
|
Agaimy A, Fuchs F, Moskalev EA, Sirbu H,
Hartmann A and Haller F: SMARCA4-deficient pulmonary
adenocarcinoma: Clinicopathological, immunohistochemical, and
molecular characteristics of a novel aggressive neoplasm with a
consistent
TTF1neg/CK7pos/HepPar-1pos
immunophenotype. Virchows Arch. 471:599–609. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dagogo-Jack I, Schrock AB, Kem M, Jessop
N, Lee J, Ali SM, Ross JS, Lennerz JK, Shaw AT and Mino-Kenudson M:
Clinicopathologic characteristics of BRG1-deficient NSCLC. J Thorac
Oncol. 15:766–776. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Naito T, Udagawa H, Umemura S, Sakai T,
Zenke Y, Kirita K, Matsumoto S, Yoh K, Niho S, Tsuboi M, et al:
Non-small cell lung cancer with loss of expression of the SWI/SNF
complex is associated with aggressive clinicopathological features,
PD-L1-positive status, and high tumor mutation burden. Lung Cancer.
138:35–42. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rekhtman N, Montecalvo J, Chang JC, Alex
D, Ptashkin RN, Ai N, Sauter JL, Kezlarian B, Jungbluth A,
Desmeules P, et al: SMARCA4-deficient thoracic sarcomatoid tumors
represent primarily smoking-related undifferentiated carcinomas
rather than primary thoracic sarcomas. J Thorac Oncol. 15:231–247.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schoenfeld AJ, Bandlamudi C, Lavery JA,
Montecalvo J, Namakydoust A, Rizvi H, Egger J, Concepcion CP, Paul
S, Arcila ME, et al: The Genomic landscape of SMARCA4
alterations and associations with outcomes in patients with lung
cancer. Clin Cancer Res. 26:5701–5708. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sui YX, Jin L, Guo GD, Luo M, Qin XY, You
LS and Chen LF: Clinicopathological analysis of the
SMARCA4-deficient non-small cell lung carcinoma. Zhonghua Bing Li
Xue Za Zhi. 50:1366–1368. 2021.(In Chinese). PubMed/NCBI
|
|
7
|
St Pierre R and Kadoch C: Mammalian
SWI/SNF complexes in cancer: Emerging therapeutic opportunities.
Curr Opin Genet Dev. 42:56–67. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Masliah-Planchon J, Bièche I,
Guinebretière JM, Bourdeaut F and Delattre O: SWI/SNF chromatin
remodeling and human malignancies. Annu Rev Pathol. 10:145–171.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Abou Alaiwi S, Nassar AH, Xie W, Bakouny
Z, Berchuck JE, Braun DA, Baca SC, Nuzzo PV, Flippot R, Mouhieddine
TH, et al: Mammalian SWI/SNF complex genomic alterations and immune
checkpoint blockade in solid tumors. Cancer Immunol Res.
8:1075–1084. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Le Loarer F, Watson S, Pierron G, de
Montpreville VT, Ballet S, Firmin N, Auguste A, Pissaloux D,
Boyault S, Paindavoine S, et al: SMARCA4 inactivation defines a
group of undifferentiated thoracic malignancies transcriptionally
related to BAF-deficient sarcomas. Nat Genet. 47:1200–1205. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fernando TM, Piskol R, Bainer R, Sokol ES,
Trabucco SE, Zhang Q, Trinh H, Maund S, Kschonsak M, Chaudhuri S,
et al: Functional characterization of SMARCA4 variants identified
by targeted exome-sequencing of 131,668 cancer patients. Nat
Commun. 11:55512020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
La Fleur L, Falk-Sörqvist E, Smeds P,
Berglund A, Sundström M, Mattsson JS, Brandén E, Koyi H, Isaksson
J, Brunnström H, et al: Mutation patterns in a population-based
non-small cell lung cancer cohort and prognostic impact of
concomitant mutations in KRAS and TP53 or STK11. Lung Cancer.
130:50–58. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Herpel E, Rieker RJ, Dienemann H, Muley T,
Meister M, Hartmann A, Warth A and Agaimy A: SMARCA4 and SMARCA2
deficiency in non-small cell lung cancer: Immunohistochemical
survey of 316 consecutive specimens. Ann Diagn Pathol. 26:47–51.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nambirajan A, Singh V, Bhardwaj N, Mittal
S, Kumar S and Jain D: SMARCA4/BRG1-deficient non-small cell lung
carcinomas: A case series and review of the literature. Arch Pathol
Lab Med. 145:90–98. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jin YP, Wang L, Wang Y, Wu DY, Zhang H and
Xia QX: [Gastric SWI/SNF complex deletion-associated
undifferentiated carcinoma with rhabdoid phenotype: A
clinicopathological and molecular analysis]. Zhonghua Bing Li Xue
Za Zhi. 51:1229–1234. 2022.(In Chinese). PubMed/NCBI
|
|
16
|
Liu SY, Mok T and Wu YL: Novel targeted
agents for the treatment of lung cancer in China. Cancer. 121
(Suppl 17):S3089–S3096. 2015. View Article : Google Scholar
|
|
17
|
Tsao MS, Nicholson AG, Maleszewski JJ,
Marx A and Travis WD: Introduction to 2021 WHO classification of
thoracic tumors. J Thorac Oncol. 17:e1–e4. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bell EH, Chakraborty AR, Mo X, Liu Z,
Shilo K, Kirste S, Stegmaier P, McNulty M, Karachaliou N, Rosell R,
et al: SMARCA4/BRG1 is a novel prognostic biomarker predictive of
cisplatin-based chemotherapy outcomes in resected non-small cell
lung cancer. Clin Cancer Res. 22:2396–2404. 2016. View Article : Google Scholar : PubMed/NCBI
|
